Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study - Wikidata - awgldk - TriplyDB

Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

http://www.wikidata.org/entity/Q34051900

about

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate).Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene.Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors.The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.Minodronate for the treatment of osteoporosis.

P2860

Q30988951-75C592D9-6F38-41F5-B6A1-852B29C470AF Q41689098-5C1C3884-6397-443A-9BD7-9F90688841A6 Q45341149-7901F97C-569A-44DD-B168-6A1ECE6A1F93 Q50184850-3BBD7B84-A824-459C-B0A4-9DFD51D4C4FC Q52613909-E040FEC3-CC33-49D6-933B-26AEABE8C798 Q55077666-15FDC476-E1BA-4F8F-8C32-74820B517CB9

P2860

Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

http://www.wikidata.org/entity/Q34051900

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@ast

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@en

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@nl

type

label

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@ast

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@en

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@nl

prefLabel

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@ast

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@en

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@nl

P1433

Q34051900-1777B149-13A1-4716-8721-93B5F233523F

P1476

Q34051900-09013341-0E76-4C40-B204-0398B134AD15

P2093

Q34051900-1CDA2B3D-DA62-420E-AB2C-A307F99A9D08

Q34051900-32C0C31F-93B8-4BAD-A6B2-45AE5C056957

Q34051900-4BE99FA7-EFCB-4E8E-AC04-FB0B6EC62EAF

Q34051900-7149ACDC-B99C-4A16-B77E-7EB62054FCCA

Q34051900-93BA0F6E-D5C1-4FBB-8A91-35F90BC3BF17

Q34051900-A2692748-9CF2-47AE-AE18-F4B49AD2D3BE

Q34051900-A75048E0-BD36-44E6-B885-FB1BB0B203CA

Q34051900-BD4481C9-859D-40FB-BF45-7E05E1B9303B

Q34051900-EA4D29C9-6F7A-43BC-98FC-FC59CEDBAFE2

Q34051900-FD3C88FF-3004-4186-9581-5B57F645E8AF

P2860

Q34051900-04FA9608-FB7C-4E53-BF5F-37C711BB70A8

Q34051900-1643B4F9-587B-47E2-BFD3-DF8A9696F760

Q34051900-2829BDAB-E18C-43D3-B1D2-9F65BFBF65FD

Q34051900-2AA08CC9-6405-4E7B-8C46-E460260CE5EF

Q34051900-37FD5107-CC0E-4955-BF1D-B8A8F3C79B3B

Q34051900-3F089F23-C847-4878-8EF9-B01588A251D4

Q34051900-6ABF7015-362D-4A08-B446-02922753145F

Q34051900-76E37AB2-12AA-49B9-A0AA-1EF37B2A0EED

Q34051900-82066E32-32B7-4985-AB84-96111937874E

Q34051900-8BA1A5CD-5FE2-4145-9A27-FCAF40B0E711

P2888

Q34051900-105A9764-7CE1-4BCE-AED1-2B7F4CD256DC

P304

Q34051900-8F54E964-99AB-4597-A798-0B79CC6B1F78

P31

Q34051900-4A0035A7-FFB2-43F9-863E-D84CAC85F4D4

P356

Q34051900-92625BF6-3E2C-4869-A3A8-C455ED7757F2

P407

Q34051900-F0C1B22D-DAD1-4C3F-9B74-20F74DE2C783

P433

Q34051900-2B18304E-0E1D-4DAA-9B20-25990439EB56

P478

Q34051900-53D717D7-BAF7-4F5A-94C4-7A3DE2E8BD7F

P50

Q34051900-5D00A789-8F50-47B3-AB47-4A324E0E4544

P577

Q34051900-6A3D24D6-E7EC-46EF-A40D-3B18C98FD738

P5875

Q34051900-53EE7519-DDCA-4AAE-9FDB-6820F8BD30AA

P6179

Q34051900-9A133879-8DBF-45A6-B050-ADDFD1E73FE1

P698

Q34051900-612AAE0C-6837-4FF4-A5CC-8CA3577F92EF

P921

Q34051900-FFCC9045-DE87-4ED7-8DC1-76A94823CE72

P932

Q34051900-0EA304CC-FACA-40DD-8066-7F899C65CE2C

P356

S00198-014-2756-8

P1433

Osteoporosis International

P1476

Clinical efficacy and treatmen ...... phonates: the BP-MUSASHI study

@en

P2093

A Sakai

http://www.w3.org/2001/XMLSchema#string

F Fukuda

http://www.w3.org/2001/XMLSchema#string

H Matsumoto

http://www.w3.org/2001/XMLSchema#string

H Tsurukami

http://www.w3.org/2001/XMLSchema#string

K Teshima

http://www.w3.org/2001/XMLSchema#string

M Nagashima

http://www.w3.org/2001/XMLSchema#string

S Arita

http://www.w3.org/2001/XMLSchema#string

S Ikeda

http://www.w3.org/2001/XMLSchema#string

T Yoshioka

http://www.w3.org/2001/XMLSchema#string

Y Okazaki

http://www.w3.org/2001/XMLSchema#string

P2860

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis

Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis

Three years of treatment with minodronate in patients with postmenopausal osteoporosis.

Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary.

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

A review of minodronic acid hydrate for the treatment of osteoporosis.

Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.

Compliance and persistence with osteoporosis therapies.

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.

Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.

P2888

s00198-014-2756-8

P304

2245-2253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-014-2756-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Nobukazu Okimoto

P577

2014-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262884697

http://www.w3.org/2001/XMLSchema#string

P6179

1012448310

http://www.w3.org/2001/XMLSchema#string

P698

24899103

http://www.w3.org/2001/XMLSchema#string

P921

P932

4134483

http://www.w3.org/2001/XMLSchema#string